PHLDA2 and non-small cell lung carcinoma: These results indicate that PHLDA2 inhibits anchorage-dependent and independent cell growth and survival in NSCLC cells, suggesting that PHLDA2-modulated pathways could be novel therapeutic targets for NSCLC.